Regulation of macrophage immune responses by antipsychotic drugs

Immunopharmacology and Immunotoxicology

Volumn 35, Issue 5, 2013, Pages 573-580

  Chen, Mao Liang ^a   Wu, Semon ^a,b   Tsai, Tzung Chieh ^c   Wang, Lu Kai ^d   Tsai, Fu Ming ^a,e  

^a TAIPEI TZU CHI HOSPITAL   (Taiwan)

^b CHINESE CULTURE UNIVERSITY   (Taiwan)

^c NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^e SOOCHOW UNIVERSITY   (Taiwan)

Author keywords

Antipsychotics; Clozapine; Haloperidol; Monocyte derived macrophages; Risperidone

Indexed keywords

CLOZAPINE; GAMMA INTERFERON; HALOPERIDOL; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; REACTIVE OXYGEN METABOLITE; RISPERIDONE;

ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL PHAGOCYTOSIS; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG POTENCY; HUMAN; HUMAN CELL; IMMUNOREGULATION; MACROPHAGE; PRIORITY JOURNAL;

ANIMALS; ANTIPSYCHOTIC AGENTS; CELL DIFFERENTIATION; CLOZAPINE; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; RISPERIDONE; TH1 CELLS; TH2 CELLS; U937 CELLS;

EID: 84884613710     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2013.828744     Document Type: Article

References (43)

1. Carlsson A, Lindqvist M. Effect of chlorpromazine or haloperidol on formation of 3methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol (Copenh) 1963;20: 140-144.
2. Haracz JL. The dopamine hypothesis: an overview of studies with schizophrenic patients. Schizophr Bull 1982;8: 438-469.
3. Tauscher J, Hussain T, Agid O, et al. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics. Am J Psychiatry 2004;161: 1620-1625.
4. Megens AA, Awouters FH, Schotte A, et al. Survey on the pharmacodynamics of the new antipsychotic risperidone. Psychopharmacology (Berl) 1994;114:9-23.
5. Miyamoto S, Duncan GE, Marx CE, Lieberman JA. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry 2005;10: 79-104.
6. Farah A. Atypicality of atypical antipsychotics. Prim Care Companion J Clin Psychiatry 2005;7:268-274.
7. Wu Y, Blichowski M, Daskalakis ZJ, et al. Evidence that clozapine directly interacts on the GABAB receptor. Neuroreport 2011;22: 637-641.
8. Markowitz JS, Brown CS, Moore TR. Atypical antipsychotics. Part I: pharmacology, pharmacokinetics, and efficacy. Ann Pharmacother 1999;33:73-85.
9. Horacek J, Bubenikova-Valesova V, Kopecek M, et al. Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia. CNS drugs 2006;20:389-409.
10. Ashby Jr CR, Wang RY. Pharmacological actions of the atypical antipsychotic drug clozapine: a review. Synapse 1996;24: 349-394.
11. Erbagci AB, Herken H, Koyluoglu O, et al. Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment. Mediators Inflamm 2001;10:109-115.
12. Zhang XY, Zhou DF, Cao LY, et al. Changes in serum interleukin-2,-6, and-8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia. J Clin Psychiatry 2004;65:940-947.
13. Cazzullo CL, Sacchetti E, Galluzzo A, et al. Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month followup study. Prog Neuropsychopharmacol Biol Psychiatry 2002;26: 33-39.
14. Kim DJ, Kim W, Yoon SJ, et al. Effect of risperidone on serum cytokines. Int J Neurosci 2001;111:11-19.
15. Chen ML, Tsai TC, Wang LK, et al. Clozapine inhibits Th1 cell differentiation and causes the suppression of IFN-gamma production in peripheral blood mononuclear cells. Immunopharm Immunol 2012;34:686-694.
16. Chen ML, Tsai TC, Lin YY, et al. Antipsychotic drugs suppress the AKT/NF-kappaB pathway and regulate the differentiation of T-cell subsets. Immunol Lett 2011;140:81-91.
17. Chen ML, Tsai TC, Wang LK, et al. Risperidone modulates the cytokine and chemokine release of dendritic cells and induces TNFalpha-directed cell apoptosis in neutrophils. Int Immunopharmacol 2012;12:197-204.
18. Ucok A, Gaebel W. Side effects of atypical antipsychotics: a brief overview. World Psychiatry 2008;7:58-62.
19. Arana GW. An overview of side effects caused by typical antipsychotics. J Clin Psychiatry 2000;61:5-11.
20. Atkin K, Kendall F, Gould D, et al. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. Br J Psychiatry 1996;169:483-488.
21. Alvir JM, Lieberman JA, Safferman AZ, et al. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States. N Engl J Med 1993;329:162-167.
22. Finkel B, Lerner AG, Oyffe I, Sigal M. Risperidone-associated agranulocytosis. Am J Psychiatry 1998;155:855-856.
23. Dernovsek Z, Tavcar R. Risperidone-induced leucopenia and neutropenia. Br J Psychiatry 1997;171:393-394.
24. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011;11:723-737.
25. Riedel M, Schwarz MJ, Strassnig M, et al. Risperidone plasma levels, clinical response and side-effects. Eur Arch Psychiatry Clin Neurosci 2005;255:261-268.
26. Mauri MC, Volonteri LS, Colasanti A, et al. Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response. Clin Pharmacokinet 2007;46:359-388.
27. Magliozzi JR, Hollister LE, Arnold KV, Earle GM. Relationship of serum haloperidol levels to clinical response in schizophrenic patients. Am J Psychiatry 1981;138:365-367.
28. Gaskill PJ, Carvallo L, Eugenin EA, Berman JW. Characterization and function of the human macrophage dopaminergic system: implications for CNS disease and drug abuse. J Neuroinflamm 2012;9:203.
29. Nakano K, Higashi T, Takagi R, et al. Dopamine released by dendritic cells polarizes Th2 differentiation. Int Immunol 2009;21: 645-654.
30. Roy B, Rai U. Dual mode of catecholamine action on splenic macrophage phagocytosis in wall lizard, Hemidactylus flaviviridis. Gen Comp Endocrinol 2004;136:180-191.
31. Ali RA, Qureshi MA, McCorkle FM. Profile of chicken macrophage functions after exposure to catecholamines in vitro. Immunopharm Immunol 1994;16:611-625.
32. Gomez F, Ruiz P, Briceno F, et al. Macrophage Fcgamma receptors expression is altered by treatment with dopaminergic drugs. Clin Immunol 1999;90:375-387.
33. Carvalho-Freitas MI, Rodrigues-Costa EC, et al. In vitro macrophage activity: biphasic effect of prolactin and indirect evidence of dopaminergic modulation. Neuroimmunomodulation 2008;15: 131-139.
34. Durk T, Panther E, Muller T, et al. 5-Hydroxytryptamine modulates cytokine and chemokine production in LPS-primed human monocytes via stimulation of different 5-HTR subtypes. Int Immunol 2005;17:599-606.
35. Cloez-Tayarani I, Petit-Bertron AF, Venters HD, Cavaillon JM. Differential effect of serotonin on cytokine production in lipopolysaccharide- stimulated human peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine2A receptors. Int Immunol 2003;15:233-240.
36. Menard G, Turmel V, Bissonnette EY. Serotonin modulates the cytokine network in the lung: involvement of prostaglandin E2. Clin Exp Immunol 2007;150:340-348.
37. Delgado PL, Charney DS, Price LH, et al. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressantinduced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 1990;47:411-418.
38. Marek GJ, Carpenter LL, McDougle CJ, Price LH. Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders. Neuropsychopharmacol 2003;28:402-412.
39. Birkett JT, Arranz MJ, Munro J, et al. Association analysis of the 5-HT5A gene in depression, psychosis and antipsychotic response. Neuroreport 2000;11:2017-2020.
40. Schreiber R, Brocco M, Audinot V, et al. (1-(2,5-Dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists. J Pharmacol Exp Ther 1995;273:101-112.
41. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008;8:958-969.
42. Benoit M, Desnues B, Mege JL. Macrophage polarization in bacterial infections. J Immunol 2008;181:3733-3739.
43. de las Casas-Engel M, Dominguez-Soto A, Sierra-Filardi E, et al. Serotonin skews human macrophage polarization through HTR2B and HTR7. J Immunol 2013;190: 2301-2310.